Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1980-05-29
1983-03-22
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31195
Patent
active
043775950
ABSTRACT:
The level of norepinephrine in neuronal synapses is regulated in order to treat depression by administering a neutral amino acid composition to a human wherein an increased brain level of norepinephrine is effected when the composition contains increased amounts of tyrosine and/or phenylalanine. Increased or decreased brain levels of serotonin are obtained when the amino acid composition contains increased or decreased amounts of tryptophan.
The neutral amino acid composition can be administered alone or concomitantly with a drug which increases or decreases noradrenergic neurotransmission.
REFERENCES:
patent: 3651237 (1972-03-01), Laborit
Cook Paul J.
Friedman Stanley J.
Massachusetts Institute of Technology
Smith, Jr. Arthur A.
LandOfFree
Process for reducing depression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for reducing depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for reducing depression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1869301